Cosyntropin Stimulation Testing is More Selective than Postoperative Day 1 Basal Cortisol for Diagnosing Secondary Adrenal Insufficiency After Unilateral Adrenalectomy.
Adrenal insufficiency
Adrenalectomy
Cushing’s Syndrome
Hypercortisolism
Journal
Annals of surgical oncology
ISSN: 1534-4681
Titre abrégé: Ann Surg Oncol
Pays: United States
ID NLM: 9420840
Informations de publication
Date de publication:
28 Jul 2024
28 Jul 2024
Historique:
received:
17
05
2024
accepted:
26
06
2024
medline:
29
7
2024
pubmed:
29
7
2024
entrez:
28
7
2024
Statut:
aheadofprint
Résumé
Secondary adrenal insufficiency (SAI) may occur in patients after unilateral adrenalectomy for adrenal-dependent hypercortisolism (HC) or primary aldosteronism (PA). This study aimed to assess whether postoperative day (POD) 1 basal cortisol was predictive of an abnormal cosyntropin stimulation test (CST) result and the need for glucocorticoid replacement (GR). A retrospective review of consecutive patients who underwent unilateral adrenalectomy for HC, PA, or both between September 2014 and September 2022 was performed. On POD1, CST was performed for all the patients with HC, and before 2021 for all the patients with PA. The patients with an abnormal CST result were deemed at risk of SAI and discharged with GR. Receiver operating characteristic (ROC) curves were generated to evaluate the sensitivity (SN) and specificity (SP) of basal cortisol thresholds to predict an abnormal CST result. The patients underwent unilateral adrenalectomy for overt hypercortisolism (OH; n = 42), mild autonomous cortisol excess (MACE; n = 70), mixed PA/HC (n = 22), or PA (n = 73). On POD1, CST was performed for 152 patients (93% OH, 96% MACE,73% PA/HC, 41% PA), and 80 patients (53%) had SAI (67% OH, 55% MACE, 44% PA/HC, 33% PA). The SN and SP of a basal cortisol level of 10 µg/dL or lower to predict an abnormal CST were respectively 92% and 77% for OH, 94% and 73% for MACE, 100% and 85% for PA, and 100% and 67% for PA/HC. The optimal basal cortisol level for predicting an abnormal CST for patients with PA or PA/HC was 5 µg/dL or lower (SN/SP, 100%). After unilateral adrenalectomy for HC, PA, or mixed PA/HC, POD1 CST improved identification of patients at risk for SAI compared with basal cortisol levels alone. The authors recommend that POD1 CST be performed to determine the risk for SAI and the need for postoperative GR after unilateral adrenalectomy for patients with HC.
Sections du résumé
BACKGROUND
BACKGROUND
Secondary adrenal insufficiency (SAI) may occur in patients after unilateral adrenalectomy for adrenal-dependent hypercortisolism (HC) or primary aldosteronism (PA). This study aimed to assess whether postoperative day (POD) 1 basal cortisol was predictive of an abnormal cosyntropin stimulation test (CST) result and the need for glucocorticoid replacement (GR).
METHODS
METHODS
A retrospective review of consecutive patients who underwent unilateral adrenalectomy for HC, PA, or both between September 2014 and September 2022 was performed. On POD1, CST was performed for all the patients with HC, and before 2021 for all the patients with PA. The patients with an abnormal CST result were deemed at risk of SAI and discharged with GR. Receiver operating characteristic (ROC) curves were generated to evaluate the sensitivity (SN) and specificity (SP) of basal cortisol thresholds to predict an abnormal CST result.
RESULTS
RESULTS
The patients underwent unilateral adrenalectomy for overt hypercortisolism (OH; n = 42), mild autonomous cortisol excess (MACE; n = 70), mixed PA/HC (n = 22), or PA (n = 73). On POD1, CST was performed for 152 patients (93% OH, 96% MACE,73% PA/HC, 41% PA), and 80 patients (53%) had SAI (67% OH, 55% MACE, 44% PA/HC, 33% PA). The SN and SP of a basal cortisol level of 10 µg/dL or lower to predict an abnormal CST were respectively 92% and 77% for OH, 94% and 73% for MACE, 100% and 85% for PA, and 100% and 67% for PA/HC. The optimal basal cortisol level for predicting an abnormal CST for patients with PA or PA/HC was 5 µg/dL or lower (SN/SP, 100%).
CONCLUSIONS
CONCLUSIONS
After unilateral adrenalectomy for HC, PA, or mixed PA/HC, POD1 CST improved identification of patients at risk for SAI compared with basal cortisol levels alone. The authors recommend that POD1 CST be performed to determine the risk for SAI and the need for postoperative GR after unilateral adrenalectomy for patients with HC.
Identifiants
pubmed: 39069580
doi: 10.1245/s10434-024-15773-0
pii: 10.1245/s10434-024-15773-0
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. Society of Surgical Oncology.
Références
Nieman LK, Biller BM, Findling JW, et al. Treatment of Cushing’s syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2015;100:2807–31. https://doi.org/10.1210/jc.2015-1818 .
doi: 10.1210/jc.2015-1818
pubmed: 26222757
pmcid: 4525003
Fassnacht M, Tsagarakis S, Terzolo M, et al. European society of endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European network for the study of adrenal tumors. Eur J Endocrinol. 2023;189:G1-42. https://doi.org/10.1093/ejendo/lvad066 .
doi: 10.1093/ejendo/lvad066
pubmed: 37318239
DeLozier OM, Dream SY, Findling JW, Carroll TB, Evans DB, Wang TS. Selective glucocorticoid replacement following unilateral adrenalectomy for hypercortisolism and primary aldosteronism. J Clin Endocrinol Metab. 2022;107:e538–47. https://doi.org/10.1210/clinem/dgab698 .
doi: 10.1210/clinem/dgab698
pubmed: 34558612
Heinrich DA, Adolf C, Holler F, et al. Adrenal insufficiency after unilateral adrenalectomy in primary aldosteronism: long-term outcome and clinical impact. J Clin Endocrinol Metab. 2019;104:5658–64. https://doi.org/10.1210/jc.2019-00996 .
doi: 10.1210/jc.2019-00996
pubmed: 31225874
Shen WT, Lee J, Kebebew E, Clark OH, Duh QY. Selective use of steroid replacement after adrenalectomy: lessons from 331 consecutive cases. Arch Surg. 2006;141:771–6. https://doi.org/10.1001/archsurg.141.8.771 .
doi: 10.1001/archsurg.141.8.771
pubmed: 16924084
Doherty GM, Nieman LK, Cutler GB Jr, Chrousos GP, Norton JA. Time to recovery of the hypothalamic-pituitary-adrenal axis after curative resection of adrenal tumors in patients with Cushing’s syndrome. Surgery. 1990;108:1085–90.
pubmed: 2247834
Waljee AK, Rogers MA, Lin P, et al. Short-term use of oral corticosteroids and related harms among adults in the United States: population-based cohort study. BMJ. 2017;357:j1415. https://doi.org/10.1136/bmj.j1415 .
doi: 10.1136/bmj.j1415
pubmed: 28404617
pmcid: 6284230
Sarnes E, Crofford L, Watson M, Dennis G, Kan H, Bass D. Incidence and US costs of corticosteroid-associated adverse events: a systematic literature review. Clin Ther. 2011;33:1413–32. https://doi.org/10.1016/j.clinthera.2011.09.009 .
doi: 10.1016/j.clinthera.2011.09.009
pubmed: 21999885
Yip L, Duh QY, Wachtel H, et al. American Association of Endocrine Surgeons guidelines for adrenalectomy: executive summary. JAMA Surg. 2022;157:870–7. https://doi.org/10.1001/jamasurg.2022.3544 .
doi: 10.1001/jamasurg.2022.3544
pubmed: 35976622
pmcid: 9386598
Ortiz DI, Findling JW, Carroll TB, et al. Cosyntropin stimulation testing on postoperative day 1 allows for selective glucocorticoid replacement therapy after adrenalectomy for hypercortisolism: results of a novel, multidisciplinary institutional protocol. Surgery. 2016;159:259–65. https://doi.org/10.1016/j.surg.2015.05.034 .
doi: 10.1016/j.surg.2015.05.034
pubmed: 26422766
Foster T, Bancos I, McKenzie T, Dy B, Thompson G, Lyden M. Early assessment of postoperative adrenal function is necessary after adrenalectomy for mild autonomous cortisol secretion. Surgery. 2021;169:150–4. https://doi.org/10.1016/j.surg.2020.05.046 .
doi: 10.1016/j.surg.2020.05.046
pubmed: 32693952
Funder JW, Carey RM, Mantero F, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101:1889–916. https://doi.org/10.1210/jc.2015-4061 .
doi: 10.1210/jc.2015-4061
pubmed: 26934393
Hurtado MD, Cortes T, Natt N, Young WF Jr, Bancos I. Extensive clinical experience: hypothalamic-pituitary-adrenal axis recovery after adrenalectomy for corticotropin-independent cortisol excess. Clin Endocrinol Oxf. 2018;89:721–33. https://doi.org/10.1111/cen.13803 .
doi: 10.1111/cen.13803
pubmed: 29968420
pmcid: 6246804
Cooper MS, Stewart PM. Corticosteroid insufficiency in acutely ill patients. N Engl J Med. 2003;348:727–34. https://doi.org/10.1056/NEJMra020529 .
doi: 10.1056/NEJMra020529
pubmed: 12594318
Peeters B, Langouche L, Van den Berghe G. Adrenocortical stress response during the course of critical illness. Compr Physiol. 2017;8:283–98. https://doi.org/10.1002/cphy.c170022 .
doi: 10.1002/cphy.c170022
pubmed: 29357129
Di Dalmazi G, Berr CM, Fassnacht M, Beuschlein F, Reincke M. Adrenal function after adrenalectomy for subclinical hypercortisolism and Cushing’s syndrome: a systematic review of the literature. J Clin Endocrinol Metab. 2014;99:2637–45. https://doi.org/10.1210/jc.2014-1401 .
doi: 10.1210/jc.2014-1401
pubmed: 24878052
Zhang CD, Li D, Singh S, et al. Glucocorticoid withdrawal syndrome following surgical remission of endogenous hypercortisolism: a longitudinal observational study. Eur J Endocrinol. 2023;188:592–602. https://doi.org/10.1093/ejendo/lvad073 .
doi: 10.1093/ejendo/lvad073
pubmed: 37395115
Weibel S, Rücker G, Eberhart LH, et al. Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis. Cochrane Database Syst Rev. 2020;10:CD012859. https://doi.org/10.1002/14651858.CD012859.pub2 .
doi: 10.1002/14651858.CD012859.pub2
pubmed: 33075160
De Oliveira Jr GS, Almeida MD, Benzon HT, McCarthy RJ. Perioperative single-dose systemic dexamethasone for postoperative pain: a meta-analysis of randomized controlled trials. Anesthesiology. 2011;115:575–88. https://doi.org/10.1097/ALN.0b013e31822a24c2 .
doi: 10.1097/ALN.0b013e31822a24c2
pubmed: 21799397
Apfel CC, Korttila K, Abdalla M, et al. A factorial trial of six interventions for the prevention of postoperative nausea and vomiting. N Engl J Med. 2004;350:2441–51. https://doi.org/10.1056/NEJMoa032196 .
doi: 10.1056/NEJMoa032196
pubmed: 15190136
pmcid: 1307533
Wood PJ, Barth JH, Freedman DB, Perry L, Sheridan B. Evidence for the low-dose dexamethasone suppression test to screen for Cushing’s syndrome: recommendations for a protocol for biochemistry laboratories. Ann Clin Biochem. 1997;34(Pt 3):222–9. https://doi.org/10.1177/000456329703400302 .
doi: 10.1177/000456329703400302
pubmed: 9158818
Schwartz J, Gan TJ. Management of postoperative nausea and vomiting in the context of an enhanced recovery after surgery program. Best Pract Res Clin Anaesthesiol. 2020;34:687–700. https://doi.org/10.1016/j.bpa.2020.07.011 .
doi: 10.1016/j.bpa.2020.07.011
pubmed: 33288119